Abigail Jenkins Named Chief Commercial and Business Officer for Lyndra Therapeutics
Lyndra Therapeutics has tapped biopharmaceutical executive Abigail Jenkins as Chief Commercial and Business Officer. She joins from Emergent BioSolutions, where she was Senior Vice President and Business Unit Head of Vaccines. Prior to that, she served Aquinox Pharmaceuticals as Chief Commercial Officer and U.S. Business Head. She has also previously held leadership roles with Relypsa, Actavis, MedImmune and Pfizer Pharmaceuticals.
Lyndra Therapeutics, based in Watertown, MA, is a developer of a novel therapeutic platform designed to sustain extended drug release in oral dosage form.